Schwartz Philip H, Brick David J, Stover Alexander E, Loring Jeanne F, Müller Franz-Josef
Center for Translational Research, Children's Hospital of Orange County Research Institute, 455 South Main Street, Orange, CA 92868-3874, USA.
Methods. 2008 Jun;45(2):142-58. doi: 10.1016/j.ymeth.2008.03.007. Epub 2008 May 29.
Human pluripotent stem cells have the unique properties of being able to proliferate indefinitely in their undifferentiated state and to differentiate into any somatic cell type. These cells are thus posited to be extremely useful for furthering our understanding of both normal and abnormal human development, providing a human cell preparation that can be used to screen for new reagents or therapeutic agents, and generating large numbers of differentiated cells that can be used for transplantation purposes. Critical among the applications for the latter are diseases and injuries of the nervous system, medical approaches to which have been, to date, primarily palliative in nature. Differentiation of human pluripotent stem cells into cells of the neural lineage, therefore, has become a central focus of a number of laboratories. This has resulted in the description in the literature of several dozen methods for neural cell differentiation from human pluripotent stem cells. Among these are methods for the generation of such divergent neural cells as dopaminergic neurons, retinal neurons, ventral motoneurons, and oligodendroglial progenitors. In this review, we attempt to fully describe most of these methods, breaking them down into five basic subdivisions: (1) starting material, (2) induction of loss of pluripotency, (3) neural induction, (4) neural maintenance and expansion, and (5) neuronal/glial differentiation. We also show data supporting the concept that undifferentiated human pluripotent stem cells appear to have an innate neural differentiation potential. In addition, we evaluate data comparing and contrasting neural stem cells differentiated from human pluripotent stem cells with those derived directly from the human brain.
人类多能干细胞具有独特的特性,能够在未分化状态下无限增殖,并分化为任何体细胞类型。因此,这些细胞被认为对于增进我们对正常和异常人类发育的理解极为有用,可提供一种人类细胞制剂用于筛选新试剂或治疗剂,并产生大量可用于移植目的的分化细胞。后者应用中的关键是神经系统疾病和损伤,迄今为止针对这些疾病的医学方法本质上主要是姑息性的。因此,将人类多能干细胞分化为神经谱系细胞已成为许多实验室的核心研究重点。这导致文献中描述了几十种从人类多能干细胞分化神经细胞的方法。其中包括生成诸如多巴胺能神经元、视网膜神经元、腹侧运动神经元和少突胶质前体细胞等不同神经细胞的方法。在本综述中,我们试图全面描述这些方法中的大部分,将它们细分为五个基本类别:(1)起始材料,(2)多能性丧失的诱导,(3)神经诱导,(4)神经维持和扩增,以及(5)神经元/胶质细胞分化。我们还展示了支持未分化的人类多能干细胞似乎具有先天神经分化潜能这一概念的数据。此外,我们评估了将从人类多能干细胞分化而来的神经干细胞与直接从人类大脑获得的神经干细胞进行比较和对比的数据。